Takeda Pharmaceutical Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
48.07 | 110.66 | -56.56% | 44.53 | +7.94% |
| P/S |
|
1.62 | 75.01 | -97.83% |
|
|
| P/BV |
|
0.952 | 70.3 | -98.65% |
|
|
| P/FCF |
|
28.99 | 79.52 | -63.55% |
|
|
| Ev/Ebitda |
|
12.93 | 18.65 | -30.64% |
|
|
| Ev/S |
|
2.65 | 72.39 | -96.34% |
|
|
| Ev/FCF |
|
48.01 | 24.55 | 95.51% |
|
|
| E/P |
|
0.0211 | -0.1123 | -118.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
20.51 | -77.27 | -126.55% | 27.31 | -24.88% |
| ROE |
|
2.11 | -9.19 | -123% |
|
|
| ROA |
|
0.9913 | -9.6 | -110.33% |
|
|
| ROIC |
|
5.63 | 9.09 | -38.11% |
|
|
| ROS |
|
3.38 | -143.83 | -102.35% |
|
|
| ROCE |
|
1.15 | 6.01 | -80.95% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.54 | -1.04 | -631.81% | 4.57 | +21.26% |
| Nеt Debt/Ebitda |
|
5.01 | 12.09 | -58.52% |
|
|
| Debt/Ratio |
|
0.3206 | 0.1394 | 129.92% |
|
|
| Debt/Equity |
|
2.86 | 18.09 | -84.17% |
|
|
| Debt/Net Income |
|
33.62 | -1.95 | -1825.67% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
6.79 | 2.66 | 155.03% | 6.09 | +11.51% |
| Number of years of dividend growth |
|
1 | 1.27 | -21.28% | ||
| DSI |
|
1 | 0.7328 | 36.47% |
|
|
| Average dividend growth |
|
1.06 | -49.62 | -102.13% |
|
|
| Average percentage for 5 years |
|
6.09 | 1.91 | 218.32% |
|
|
| Average percentage for payments |
|
190.26 | 33.37 | 470.13% |
|
|
| Difference from average difference in sector |
|
4.13 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
29.55 | 53.88 | -45.16% | ||
| Growth impulse Ebitda in 5 years |
|
30.18 | 12.48 | 141.83% | ||
| Growth impulse Net Income in 5 years |
|
225.64 | -8.53 | -2745.25% | ||
| Growth impulse FCF in 5 years |
|
-47.88 | -13.75 | 248.22% | ||
| Growth impulse EPS in 5 years |
|
222.73 | -67.8 | -428.51% |
IP Score
4.95/10
